Immunological Cross-Reactivities of Woodchuck and Hepatitis
|
|
- Chester Greer
- 6 years ago
- Views:
Transcription
1 INFECTION AND IMMUNITY, Feb. 1982, p /82/ $02.00/0 Vol. 35, No. 2 Immunological Cross-Reactivities of Woodchuck and Hepatitis B Viral Antigens IRVING MILLMAN,* THERESA HALBHERR, AND HEIDI SIMMONS Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania Received 5 August 1981/Accepted 29 September 1981 Woodchuck sera were tested for antigens and antibodies with tests which detect human hepatitis virus antigens and antibodies. Data on 264 woodchuck sera are presented. Summers et al. (5), Werner et al. (6), Cummings et al. (1), and Snyder and Summers (4) have described viruses similar to hepatitis B virus (HBV) in woodchucks (woodchuck hepatitis virus lwhv]), Marmota monax. Werner et al. (6) reported that antigens found on the cores of human and woodchuck viruses are crossreactive but that there is a lack of cross-reactivity between the surface antigens of the two viruses in immunodiffusion experiments, suggesting that the major antigenic determinants of the viral surfaces are different. More sensitive passive hemagglutination tests indicate that there are common minor surface determinants. These findings are in agreement with their liquid hybridization experiments, in which they showed 3 to 5% homology. Galibert et al. (G. Galibert, T. N. Chen, and E. Mandart, Proc. Natl. Acad. Sci. U.S.A., in press) compared the section of HBV DNA which codes for the hepatitis B surface antigen (HBsAg) with the equivalent section of WHV DNA. They found that 487 of 678 residues were identical; that is, the homology for the surface antigen genes was 78%. Feitelson et al. (2) compared the surface antigens of human and ground squirrel hepatitis virus and WHV both serologically and by tryptic peptide mapping. Although only two woodchuck sera were studied, these authors concluded that there is a close relationship among all three. These findings predict that immunological crossreactivity should be greater than that reported by Werner et al. (6). This paper includes data on the cross-reactivity with HBV of 264 sera from woodchucks trapped in Pennsylvania and Delaware. These sera were assayed with commercial reagents (Abbott Laboratories, North Chicago, Ill.) designed to detect HBV antigens and antibodies in human sera. These included the Ausria II radioimmunoassay (RIA) and Auszyme enzyme immunoassay (EIA) kits for the detection of HBsAg, the Ausab RIA kit for the detection of antibody to hepatitis B surface antigen (anti- HBs), the Corab RIA kit for the detection of antibody to hepatitis B core antigen (anti-hbc) or hepatitis B core antigen (HBcAg), and RIA kits for the detection of the e antigen that is closely associated with hepatitis B infection (HBeAg) and antibody to the e antigen (anti- HBe; Abbott Laboratories). Woodchuck sera were collected from three sources. Our primary source was Cocalico Woodchuck Farms, Reinhold, Pa., where 216 sera were collected. These sera were collected mainly in Delaware. Our second source was a colony of M. monax maintained by our laboratory at the New Bolton Center of the University of Pennsylvania School of Veterinary Medicine in Chester County, Pennsylvania, where 37 sera were collected. Lastly, 11 sera were from the woodchuck colony maintained by Robert Snyder at the Penrose Laboratories of the Philadelphia Zoological Gardens. Guinea pig anti-woodchuck surface antigen (anti-whs) was produced by centrifuging woodchuck serum containing WHV at 160,500 x g for 4 h in a Ti 60 rotor (Beckman Instruments, Inc., Fullerton, Calif.) at 2 C. The pellet containing virus was suspended in physiological saline and mixed with complete Freund adjuvant (three parts of Freund adjuvant with one part of the antigen suspension). Twelve guinea pigs were injected subcutaneously with this suspension at multiple sites. At the end of 6 weeks, a booster of the WHV suspension was injected subcutaneously. Animals were bled by cardiac puncture 7 days after the last injection and then at 4-week intervals. Several precipitating antibodies were found by immunodiffusion (ID), including one which reacted solely with woodchuck sera positive for WHV. All antibodies which did not react with WHV were removed by absorption with one or two parts of woodchuck serum which did not contain WHV. The absorbed guinea pig antiserum produced a heavy precipitin band forming a line of identity with that of antiserum against WHV which occurs naturally in woodchucks. This guinea pig antiserum did not react by ID with purified woodchuck hepatitis core antigen 752
2 VOL. 35, 1982 NOTES 753 (WHcAg) isolated from woodchuck liver. Since we were able to absorb all precipitating antibody with purified woodchuck hepatitis surface antigen (WHsAg), we concluded that our guinea pig antiserum contained only anti-whs. Of the 264 woodchucks in this survey, 18 had naturally acquired anti-whs in their sera. Orcein staining (3) produced a magenta coloration similar to that produced by HBsAg-anti-HBs precipitin bands. Woodchuck sera which reacted with reagents designed to detect HBsAg were considered presumptive positives for WHsAg. As a rule, either RIA or EIA (peroxidase-linked assay) was used. To confirm these presumptive-positive tests, the woodchuck sera in question were incubated with an equal volume of either woodchuck anti-whs or guinea pig anti-whs for 2 h at 37 C and 18 h at 5 C. A drop in count (by RIA) or optical density (by EIA) of 50% or more compared with controls (same woodchuck serum combined with either woodchuck or guinea pig serum known to contain no anti-whs) was considered a positive confirmed test. Woodchuck sera which reacted with reagents designed to detect anti-hbs were considered presumptive positives for anti-whs. These were confirmed in the same manner as were the presumptive positives for WHsAg, except these presumptive-positive woodchuck sera were incubated with woodchuck sera known to contain WHsAg. A drop in count of 50% or more (by RIA) indicated a positive confirmed test for anti-whs. Presumptive-positive tests for HBcAg, anti-hbc, HBeAg, and anti-hbe were not confirmed but were considered positive solely on the basis of reacting with the reagents designed to detect the equivalent antigens and antibodies in human sera. Confirmation assays were also conducted by immunodiffusion, where the presumptive-positive woodchuck sera incubated with their counterparts, antibodies or antigens, were shown to no longer produce a precipitin reaction against either constituent of the mixture. Since results with Ausria II and Auszyme did not differ when any of our sera were tested for HBsAg or WHsAg, we used either test and, more often, both. To determine the sensitivity of Ausria II or Auszyme for the detection of WHsAg, 18 positive sera were diluted to 1: 20,000, using normal human sera as diluent. A ratio of 2.1 or more was considered positive for HBsAg. We assumed the same conditions for WHsAg. The results of this evaluation (Table 1) show that 5 of 17 positive sera in the 1:10 dilution could be detected in a dilution of 1: 20,000. The number of positives detected increased with an increase in concentration. The results of testing 24 woodchuck sera for other HBV markers are shown in Table 2. Other antigens and antibodies detected by cross-reactivity (Table 2) were anti-woodchuck core antigen (anti-whc) (by Abbott's Corab), anti-whs (by Abbott's Ausab), and woodchuck hepatitis e antigen (WHeAg) and anti-woodchuck e antigen (anti-whe) (using Abbott's HBeAg and anti-hbe assays). We found (Tables 1, 2, and 3) that there appeared to be no association of anti-whc assayed by RIA with WHsAg assayed by RIA. Unlike human hepati- TABLE 1. Cross-reactivity of woodchuck sera with HBsAg, using RIA (Ausria II) Ratio (cpm test/cpm controls) with following dilutiona: Woodchuck serum 1:1 1:10 1:100 1:1000 1:2000 1:4000 1:8000 1:10,000 1:20, ND NDb ND ND ND ND ND ND ,1.9C ND a A ratio of 2.1 or more was considered positive. Numbers b represent the mean of seven normal human sera. ND, Not done. c Assayed twice, 1 month apart.
3 754 NOTES INFECT. IMMUN. TABLE 2. Cross-reactivity of woodchuck sera with different HBV assay reagents Presence of Presence of Presence of Woodchuck serum HBsAg by anti-hbc by Ausria II Coraba Anti-HBs by Ausubb HBeAgC anti-hbed ND NDe ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND 2.7 ND ND 3.2 ND ND 3.3 ND ND 1.2 ND ND 1.8 ND ND 2.2 ND ND 2.1 ND ND 1.8 ND ND 2.7 ND ND 2.Of ND (weak) - ND ND a The presence of anti-hbc is determined by comparing the net counts per minute of the specimen to a cutoff value. The cutoff value is the mean of the negative controls plus the mean of the positive controls divided by 2. Specimens whose counts per minute are less than the cutoff value are Corab positive. b A ratio of 2.1 or greater is considered positive. c A ratio of 2.1 or greater is considered positive. d The presence of anti-hbe is determined by comparing the net counts per minute of the specimen to a cutoff value. The cutoff value is the mean of the negative controls plus the mean of the positive controls divided by 2. Specimens whose counts per minute are less than the cutoff value are anti-hbe positive. ' ND, Not done. f At 1:5 dilution. tis B, where all sera containing HBsAg also contain anti-hbc, sera from woodchucks with WHsAg did not always contain anti-whc. We are confident of the reliability of the crossreactivity assay for WHsAg (Table 3). The reliability of the cross-reactivity assay for anti-whc has not been tested because there are no commercial assays for woodchuck antigens. If we assume that the cross-reactivity assay for anti- WHc is reliable, then there is no association between anti-whc and WHsAg. Another way to determine this is by use of a direct test with ID and purified WHcAg. A total of 45 WHsAgpositive sera were selected from our 264 woodchuck sera collection and tested for anti-whc. All 45 were negative. While we would have expected some positives on the basis of the data shown in Table 3, we could attribute these results to a lack of sensitivity of the ID assay. Of 253 sera tested for anti-whs, 14 (Table 3) proved positive by RIA for anti-hbs and 9 by ID for anti-whs. Of the original 264 sera, 11 could not be included because of insufficient quantity. Of 253 sera, 235 proved negative by both assays, whereas only 5 assayed positive by both assays. These five and the others (nine positive by RIA and four positive by ID only) were confirmed as positive by absorption with sera containing WHsAg. Anti-WHs was mixed with an equal volume of woodchuck serum containing
4 VOL. 35, 1982 WHsAg. After an incubation of 2 h at room temperature, no precipitin band formed by immunodiffusion. Those positive by ID also produced lines of identity with woodchuck anti- WHs. When ID and Ausria II or Auszyme were compared for the detection of WHsAg, using 253 woodchuck sera (Table 3), a strong and significant association of the two assays was found when analyzed by the chi-square test. One woodchuck serum was positive by ID (reacting with both guinea pig and woodchuck anti-whs) and negative by both Ausria II and Auszyme. Woodchuck sera positive for WHsAg by Ausria II and Auszyme could be confirmed by neutralization with both guinea pig or woodchuck anti- WHs. Confirmation was shown by incubating woodchuck positive sera with either guinea pig or woodchuck anti-whs for 2 h at 37 C before testing or by the procedure recommended by Abbott Laboratories in which guinea pig or woodchuck anti-whs is incubated with polystyrene beads containing a complex of antibody and antigen before the addition of "SI-labeled anti- HBs. In either case, a drop in count of 50% or more was considered a positive confirmation. (6 I, It.4.. I, I/ I t i 0 5..dI_. I NOTES 755 Confirmations were never achieved when human anti-hbs was used in the above procedures, nor could WHsAg be neutralized by human anti-hbs when tested by ID (Fig. 1). However, complete neutralization was achieved with guinea pig and woodchuck anti-whs. However, when human serum containing HBsAg was incubated with woodchuck or guinea pig anti- WHs, anti-whs activity was still present, and HBsAg disappeared by RIA or ID. This indicates that anti-whs may contain antibodies to all determinants of WHsAg, whereas, anti-hbs may lack antibodies for some determinants of WHsAg. These data are in accord with those of Galibert et al. (in press) and indicate high immunological cross-reactivities of WHsAg and HBsAg which could be expected with 78% homology. Furthermore, high cross-reactivities can also be found with WHeAg and anti-whe. These close antigenic relationships between antigens and antibodies of WHV and human HBV should make it relatively easy for investigators to look for markers of WHV infection with established HBV assays. The differences observed when testing for anti-whs, using Ausab and ID, may i o J L 3 X > ell, f 4 FIG. 1. ID pattern showing that human anti-hbs does not block the reaction between guinea pig anti-whs and WHsAg. The center well (0) contains guinea pig anti-whs. Wells 1 and 4 contain serum from a positive woodchuck. Wells 2 and 3 contain serum of the positive woodchuck absorbed with two different human anti-hbs sera. Well 5 is a control containing serum of a positive woodchuck absorbed with serum from a normal woodchuck. Well 6 contains serum of a normal woodchuck which was used for the absorption in well 5.
5 756 NOTES INFECT. IMMUN. 4)~~~~~~~~~~~~~~~~~~~~~~~~~1 N4)~~~~~~~~~~~~~~~~1 ~~~U~ ~ W)WI)~~~~~~~~,1 40 ~ ~ ~ ~ ~~~06C~ ~.o 40~~~~~~~~~~~~0 ~~~~~~~~0~ ~ ~ ~ ~ O 4) 44) U~~~~~~~~~~~~~~~~~~~~~~~~~~~~~4,U 4) 4.) U' 0. 4)~~~~~~~~~~~~~~~~~~~~~~~. 40~~~~~~~~~ -~~~~ 4)~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~0 co.- 0,,u~~ ~ ~ ~ ~ ~ ~ ~ ~ ~
6 VOL. 35, 1982 NOTES 757 reflect differences in subtypes of WHsAg, since nine woodchuck sera were found positive by Ausab but negative by ID, and four were positive by ID and negative by Ausab (Table 3). Furthermore, the inability to completely absorb all WHsAg antibodies with HBsAg indicates determinants on WHsAg which are missing on HBsAg. The low incidence of anti-whc in woodchuck sera containing surface antigen should make the isolation of WHc particles from woodchuck livers easier than it has been to isolate HBcAg from human livers. This work was supported by Public Health Service grants CA-06551, RR-05539, and CA from the National Institutes of Health and by an appropriation from the Commonwealth of Pennsylvania. LITERATURE CITED 1. Cummigs, I. W., J. K. Browne, W. A. Salsis, G. V. Tyler, R. L. Snyder, J. M. Smolec, and J. Summers Isolation, characterization and comparison of recombinant DNAs derived from genomes of human hepatitis B virus and woodchuck hepatitis virus. Proc. Natl. Acad. Sci. U.S.A. 77: Feitelson, M. A., P. L. Marion, and W. S. Robinson Antigenic and structural relationships of the surface antigens of hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus. J. Virol. 39: Shikata, T., T. Uzawa, N. Yoshiwara, T. Akatsuka, and S. Yamayold Staining methods of Australia antigen in paraffin sections. Detection of cytoplasmic inclusion bodies. Jpn. J. Exp. Med. 44: Snyder, R. L., and J. Summers Woodchuck hepatitis virus and hepatocellular carcinoma. p In M. Essex, G. Todaro, and H. zur Hausen (ed.), Viruses in naturally occurring cancers. Cold Spring Harbor Conferences on Cell Proliferation, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 5. Summers, J., J. M. Smolec, and R. L. Snyder A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. U.S.A. 75: Werner, B. G., J. M. Smolec, R. Snyder, and J. Summers Serological relationship of woodchuck hepatitis virus to human hepatitis B virus. J. Virol. 32: Downloaded from on June 27, 2018 by guest
Woodchuck Hepatitis Virus, as Measured by New, Specific
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1982, p. 484-49 95-1137/82/3484-7$2./ Vol. 15, No. 3 Natural and Experimental Infection of Woodchucks with Woodchuck Hepatitis Virus, as Measured by New, Specific
More informationTherapeutic immunization strategies in chronic hepatitis B
Therapeutic immunization strategies in chronic hepatitis B Mengji Lu Institut für Virologie Universitätsklinkum Essen Falk Symposium Berlin, 04. October 2005 The aim of therapeutic immunization to achieve
More informationSerological Markers in Chimpanzees
INFECTION AND IMMUNITY, May 1979, p. 352-356 Vol. 24, No. 2 0019-9567/79/05-0352/05$02.00/0 Hepatitis B e-antigen and Its Correlation with Other Serological Markers in Chimpanzees CHUNG-MEI LING,* ISA
More informationantibody screening in patients attending a clinic for sexually
J. Hyg., Camb. (1984), 93, 225-232 225 Printed in Great Britain Hepatitis B core antigen synthesised in Escherichia coli: its use for antibody screening in patients attending a clinic for sexually transmitted
More informationMicroscopy. (HB.Ag, Australia antigen) and the hepatitis B 11, 12, 18). This report describes the purification and
JOURNAL OF VIROLOGY, Dec. 1974, p. 1552-1558 Copyright 0 1974 American Society for Microbiology Vol. 14, No. 6 Printed in U.S.A. Hepatitis B Core Antigen: Immunology and Electron Microscopy LEWELLYS F.
More informationIdentification of Microbes Lecture: 12
Diagnostic Microbiology Identification of Microbes Lecture: 12 Electron Microscopy 106 virus particles per ml required for visualization, 50,000-60,000 magnification normally used. Viruses may be detected
More informationDocumentation, Codebook, and Frequencies
2 Documentation, Codebook, and Frequencies Laboratory Component: Hepatitis B: core antibody, surface antibody and surface antigen; Hepatitis C: confirmed antibody; Hepatitis D antibody Survey Years: 2003
More informationRadioimmunoassay for Detection of Hepatitis B e Antigen and its Antibody. Results of Clinical Evaluation
Radioimmunoassay for Detection of Hepatitis B e Antigen and its Antibody. Results of Clinical Evaluation ISA K. MUSHAHWAR, PH.D., LARRY C. MCGRATH, PH.D., JAMES DRNEC, PH.D., AND LACY R. OVERBY, PH.D.
More informationThe Alphabet Soup of Viral Hepatitis Testing
The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,
More informationHBV-2 Group: neonates born to HBsAg+ and HBeAg+ mothers who received a 4-dose vaccination regimen (Part of
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationViral hepatitis. The word hepatitis means inflammation of the liver. There are five main types of viral hepatitis: A, B, C, D, E
Viral hepatitis The word hepatitis means inflammation of the liver There are five main types of viral hepatitis: A, B, C, D, E Hepatitis A and E are typically caused by ingestion of contaminated food or
More informationEffect of Vaccine, Route, and Schedule on Antibody
APPUED MICROBIOLOGY, Mar. 1969, p. 355-359 Copyright 1969 American Society for Microbiology Vol. 17, No. 3 Printed in U.S.A. Effect of Vaccine, Route, and Schedule on Antibody Response of Rabbits to Pasteurella
More informationApplication of a screening test for antibody
Application of a screening test for antibody to hepatitis B core antigen B. J. COHEN AND Y. E. COSSART J. clin. Path., 1977, 3, 79-713 From the Virus Reference Laboratory, Central Public Health Laboratory,
More informationHuman HBcAb IgM ELISA kit
Human HBcAb IgM ELISA kit Catalog number: NR-R10163 (96 wells) The kit is designed to qualitatively detect HBcAb IgM in human serum or plasma. FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC PURPOSES
More informationFailure of Preexisting Antibody Against Hepatitis B Surface Antigen to Prevent Subsequent Hepatitis B Infection
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1983, p. 305-309 Vol. 18, No. 2 0095-1137/83/080305-05$02.00/0 Copyright C 1983, American Society for Microbiology Failure of Preexisting Antibody Against Hepatitis
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationLab Underwriting Puzzler. Presented by: Bill Rooney, M.D.
Lab Underwriting Puzzler Presented by: Bill Rooney, M.D. Obtaining Best Results from this presentation For best results please do the following: Select Slide Show from the menu option on top Select From
More informationHepatitis B surface antigen Ab ELISA Kit
Hepatitis B surface antigen Ab ELISA Kit Catalog Number KA0287 96 assays Version: 22 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3
More informationEnzyme-Linked Immunosorbent Assay for Detection of Immunoglobulin M Antibody to Hepatitis B Core Antigen
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1981, p. 405-409 0095-1137/81/030405-05$02.00/0 Vol. 13, No. 3 Enzyme-Linked Immunosorbent Assay for Detection of Immunoglobulin M Antibody to Hepatitis B Core Antigen
More informationhepatocellular carcinoma
Journal of Clinical Pathology, 1977, 30, 1124-1128 Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma M. L. TURBITT, R. S. PATRICK, R.
More informationExperimental WHV Infection Histogenesis of Viral HCC
In: 55th Annual Meeting of the American College of Veterinary Pathologists (ACVP) & 39th Annual Meeting of the American Society of Clinical Pathology (ASVCP), ACVP and ASVCP (Eds.) Publisher: American
More informationfor detecting antibody to hepatitis B virus core antigen
Journal of Clinical Pathology, 1978, 31, 832-836 Routine use of counter-immunoelectrophoresis test for detecting antibody to hepatitis B virus core antigen R. FREEMAN AND M. H. HAMBLING From the Virology
More informationSpecificity and Sensitivity of Radioimmunoassay for Hepatitis
APPLIED MICROBIOLOGY, Oct. 1974, P. 600-604 Copyright 0 1974 American Society for Microbiology Vol. 28, No. 4 Printed in U.S.A. Specificity and Sensitivity of Radioimmunoassay for Hepatitis B Antigen GILBERT
More informationacute hepatitis B and persists for several months to more than 2 years, depending on the sensitivity
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1981, p. 544549 00951 137/81/11054406$02.00/0 Vol. 14, No. 5 Determination of Immunoglobulin M Antibodies Against Hepatitis B Core Antigen and Hepatitis A Virus by
More informationNOTES. tubes or in 150-cm2 flasks. The growth medium. was Eagle minimum essential medium with
INFECTION AND IMMUNITY, Nov. 198, p. 67-611 19-9567/8/11-67/5$2./ Vol. 3, No. 2 NOTES PLC/PRF/5 (Alexander) Hepatoma Cell Line: Further Characteriation and Studies of Infectivity RICHARD J. DAEMER,I* STEPHEN
More informationSee external label 2 C-8 C = C-REACTIVE PROTEIN (CRP) LATEX SLIDE TEST
CORTEZ DIAGNOSTICS, INC. 21250 Califa Street, Suite 102 and 116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationReceived 17 May 2008/Returned for modification 1 July 2008/Accepted 25 July 2008
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2008, p. 3617 3632 Vol. 52, No. 10 0066-4804/08/$08.00 0 doi:10.1128/aac.00654-08 Copyright 2008, American Society for Microbiology. All Rights Reserved. Antiviral
More informationHepadnaviridae family (DNA) Numerous antigenic components Humans are only known host May retain infectivity for more than 7 days at room temperature
Hepatitis B Epidemic jaundice described by Hippocrates in 5th century BC Jaundice reported among recipients of human serum and yellow fever vaccines in 1930s and 1940s Australia antigen described in 1965
More informationJ. L. Melnick. Introduction. Hepatitis B Antigens. VIROLOGY l Melnick l HEPATITIS VIRUSES 341
VIROLOGY l Melnick l HEPATITIS VIRUSES 341 HEPATITIS VIRUSES J. L. Melnick Discovery of a surface antigen closely associated with the agent of viral he$atitis B has hel$ed pave the way for work on a vaccine
More informationChanges in hepatitis B virus DNA polymerase in
Gut, 1979, 20, 190-195 Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B A. ALBERTI, S. DIANA, A. L. W. F. EDDLESTON, AND ROGER WILLIAMS From the Liver Unit,
More informationHuman Influenza A (Swine Flu) Rapid test
Human Influenza A (Swine Flu) Rapid test Cat.No: DTSXY-Z9 Lot. No. (See product label) Size 20T Intended use The Influenza A (Swine Flu) test is a rapid chromatographic immunoassay for the qualitative
More informationRelationship between the Replication of Hepatitis B Virus and the Localization of Virus Nucleocapsid Antigen (HBcAg) in Hepatocytes
J. gen. Virol. (1987), 68, 871-877. Printed in Great Britain 871 Key words: HBV/HBcAg/localization Relationship between the Replication of Hepatitis B Virus and the Localization of Virus Nucleocapsid Antigen
More informationAccuSet HBV Worldwide Performance Panel
PACKAGE INSERT 0805-033 INTENDED USE The is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot HBV test methods. Characterized samples
More informationContinuing Studies of Transmission of Hepatitis B Virus to Gibbons by Exposure to Saliva Containing Hepatitis B Surface Antigen
Continuing Studies of Transmission of Hepatitis B Virus to Gibbons by Exposure to Saliva Containing Hepatitis B Surface Antigen Principal Investigators : Associate. Investigators : Robert McNair Scott,
More informationHBV Core and Core-Related Antigen Quantitation in Chinese Patients with. Chronic Hepatitis B Genotype B and C Virus Infection
Title page HBV Core and Core-Related Antigen Quantitation in Chinese Patients with Chronic Hepatitis B Genotype B and C Virus Infection Short Title: Quantitation of HBc and HBcrAg in Chinese patients Akinori
More informationLaboratory Diagnosis of Viral Infections. G. Jamjoom 2005
Laboratory Diagnosis of Viral Infections G. Jamjoom 2005 Five Main Techniques: Virus Culture and Isolation Serology Rapid Detection of Viral Antigens Detection of Viral Nucleic Acid Electron Microscopy
More informationIVD information *Droppers for the sensitized and control cells. Not for use other than dispensing the sensitized and control cells.
In Vitro Diagnostic Reagent Instruction Manual of Diagnostic Reagent for Determination of anti-hbs Thoroughly read this instruction manual before use of this kit Background of the development and features
More informationVirion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics
Hepadnaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Hepatitis viruses A group of unrelated pathogens termed hepatitis viruses cause the vast majority
More informationViral hepatitis Blood Born hepatitis. Dr. MONA BADR Assistant Professor College of Medicine & KKUH
Viral hepatitis Blood Born hepatitis Dr. MONA BADR Assistant Professor College of Medicine & KKUH Outline Introduction to hepatitis Characteristics of viral hepatitis Mode of transmission Markers of hepatitis
More informationEvaluation of Enzyme Immunoassay for Diagnosis of Hepatitis
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1981, p. 618-626 0095-1137/81/040618-09$02.00/0 Vol. 13, No. 4 Immunoglobulin M Antibodies to Hepatitis B Core Antigen: Evaluation of Enzyme Immunoassay for Diagnosis
More informationMouse HBsAg(Hepatitis B Virus Surface Antigen) ELISA Kit
Mouse HBsAg(Hepatitis B Virus Surface Antigen) ELISA Kit Catalogue No.: EM0002 Size: 96T Reactivity: Mouse Application: This immunoassay kit allows for the qualitative determination of HBsAg in Mouse serum
More informationRapid-VIDITEST Swine Flu
Rapid-VIDITEST Swine Flu One Step Influenza type A Antigen Card test. Instruction manual Producer: VIDIA spol. s r.o., Nad Safinou II 365, 252 50 Vestec, Czech Republic, Tel.: +420 261 090 565, www.vidia.cz
More informationHBeAg and HBeAg Ab ELISA Kit
HBeAg and HBeAg Ab ELISA Kit Catalog Number KA0290 96 assays Version: 17 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Principle of the Assay... 3
More informationIdentification and transmission of hepatitis B virus-related variants
Proc. Nati. Acad. Sci. USA Vol. 83, pp. 6608-6612, September 1986 Medical Sciences dentification and transmission of hepatitis B virus-related variants (hepatitis B virus DNA/hepatitis B surface antigen/radioimmunoassay)
More informationEvaluation Report MHRA Four anti-hbc assays. 60 (Free to NHS) MHRA Report number MHRA Evaluation Report. Crown Copyright.
November 2003 NUMBER Evaluation Report MHRA 03136 Four anti-hbc assays MHRA Evaluation Report MHRA Report number 03136 Crown Copyright 60 (Free to NHS) WHAT YOU CAN EXPECT FROM MHRA EVALUATION REPORTS
More informationLearning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses.
Learning Objectives: Hepatitis Update ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Upon attendance of this seminar and review of material provided, the attendees will be able to: 1. List hepatitis viruses
More informationThis document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
2002D0364 EN 01.07.2012 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION DECISION of 7 May 2002 on common technical
More informationPlease use only the valid version of the package insert provided with the kit.
Please use only the valid version of the package insert provided with the kit. Intended Use For the qualitative screening of serum IgG antibodies to Trichinella using an Enzyme Linked Immunoabsorbant Assay
More informationDistribution of HBcAg in hepatitis B detected by immunoperoxidase staining with three different preparations of anti-hbc antibodies
J Clin Pathol 1989;42:284-288 Distribution of HBcAg in hepatitis B detected by immunoperoxidase staining with three different preparations of anti-hbc antibodies S KAKUMU, M ARAO, K YOSHIOKA, Y TSUTSUMI,
More informationRubella Latex Agglutination Test
Rubella Latex Agglutination Test Cat. No.:DLAT1088 Pkg.Size:30T Intended use The Rubella Latex Agglutination Test is a rapid latex particle agglutination test for the qualitative and semi-quantitative
More informationCDC website:
Hepatitis B virus CDC website: http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_b/slide_1.htm Relevance Key Features es of Hepatitis t B Virus 250 million people infected worldwide. In areas of
More informationRama Nada. - Malik
- 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect
More informationHepatitis B. Hepatitis Viruses. Hepatitis Viruses. Hepatitis Viruses
Hepatitis Viruses Hepatitis B History and Overview of Hepatitis B Testing in Australia Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Cytomegalovirus Epstein-Barr Virus Hepatitis Viruses Hepatitis
More informationOfficial Journal of the European Communities COMMISSION
16.5.2002 EN Official Journal of the European Communities L 131/17 COMMISSION COMMISSION DECISION of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (notified under
More informationHEPATITIS VIRUSES. Other causes (not exclusively hepatitis v.)also called sporadic hepatitis: HEPATITIS A(infectious hepatitis)
Dept.of Microbiology/Virology Assist.prof. Shatha F. Abdullah HEPATITIS VIRUSES Medically important hepatitis v. (liver)are: 1.HAV 2.HBV 3.HCV 4.HDV 5.HEV 6.HGV Other causes (not exclusively hepatitis
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091608 Age 26 Years Gender Female 30/8/2017 92900AM 30/8/2017 94717AM 31/8/2017 90216AM Ref By Final HEATITIS ACUTE VIRUS CONFIRMATION HEATITIS A ANTIBODY (ANTI HAV),
More informationHEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM
HEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM Event Name: Event Time Period: ACUTE Clinical Presentation (CDC 2012): CDC Event (2012): HEPB Lifelong immunity An acute illness with a discrete
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationViral antigens and antibodies in hepatitis B infection
Journal of Clinical Pathology, 1978, 31, 681-687 Viral antigens and antibodies in hepatitis B infection C. R. HOWARD, A. R. ZANETTI,1 SARA THAL, AND A. J. ZUCKERMAN From the Department of Medical Microbiology
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091650 Age 49 Years Gender Male 29/8/2017 120000AM 29/8/2017 100248AM 29/8/2017 105306AM Ref By Final HEATITIS, VIRAL, COMREHENSIVE ANEL HEATITIS A ANTIBODY (ANTI
More informationIn the Name of God. Talat Mokhtari-Azad Director of National Influenza Center
In the Name of God Overview of influenza laboratory diagnostic technology: advantages and disadvantages of each test available Talat Mokhtari-Azad Director of National Influenza Center Tehran- Iran 1 1)
More informationSolid-phase enzyme-immunoassay for detection of
J. clin. Path., 1976, 29, 873-879 Solid-phase enzyme-immunoassay for detection of hepatitis B surface antigen G. WOLTERS, L. KUIJPERS, J. KACAKI, AND A. SCHUURS From the Organon Scientific Development
More informationThe value of screening blood donors for antibody to hepatitis B core antigen
J Clin Pathol 1983;36:924-928 The value of screening blood donors for antibody to hepatitis B core antigen AC ARCHER, BJ COHEN, PP MORTIMER From the South West Regional Blood Transfusion Centre, Southmead
More informationHAV HBV HCV HDV HEV HGV
Viral Hepatitis HAV HBV HCV HDV HEV HGV Additional well-characterized viruses that can cause sporadic hepatitis, such as yellow fever virus, cytomegalovirus, Epstein-Barr virus, herpes simplex virus, rubella
More informationInnovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES
Innovation in Diagnostics ToRCH A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES EN TOXOPLASMOSIS Toxoplasmosis is a parasitic disease caused by with the obligate intracellular
More informationDiagnosis of California La Crosse Virus Infection by Counterimmunoelectrophoresis
JOURNAL OF CLINICAL MICROBIOLOGY, June 97, p. 60-60 009-7/7/0007-060$0.00/0 Copyright 97 American Society for Microbiology Diagnosis of California La Crosse Virus Infection by Counterimmunoelectrophoresis
More informationScreening and Diagnosis of Hepatitis Virus Infections
Screening and Diagnosis of Hepatitis Virus Infections Prof. Jean-Michel Pawlotsky, MD, PhD National Reference Center for Viral Hepatitis B, C and delta Department of Virology & INSERM U955 Henri Mondor
More informationFINAL REPORT HBV Serology External Quality Assessment Scheme
FINAL REPORT HBV Serology External Quality Assessment Scheme Programme codes: HBVC4310, HBVC435 Panel ID: 2008/Mar/11 HBV Serology EQAS Panel ID 2008/Mar/11 Page 1 of 9 The NRL is a: NATA-accredited proficiency
More informationImmunologic Cross-Reaction Between Luteinizing Hormone and Human Chorionic Gonadotropin
Immunologic Cross-Reaction Between Luteinizing Hormone and Human Chorionic Gonadotropin MELVIN L. TAYMOR, M.D., DONALD A. GOSS, M.D., and ALBERT BUYTENDORP, M.D. RECENTLY a number of reports 2 4 have indicated
More informationSerology for Biochemists
Serology for Biochemists Dr Ronda Greaves Diagram from: http://www.cdc.gov/hepatitis/resources/professionals/training/serology/training.htm Overview Part A: GENERAL SEROLOGY IgG vs IgM Definitions The
More informationDiagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)
Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves
More informationDetection of human antibodies to hepatitis B surface
Journal of Clinical Pathology, 1979, 32, 1264-1271 Detection of human antibodies to hepatitis B surface antigen (HBsAg) by an enzyme-immunoassay for HBsAg G. WOLTERS, L. KUIJPERS, AND A. SCHUURS From the
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091606 Age 24 Years Gender Male 30/8/2017 92800AM 30/8/2017 94631AM 31/8/2017 90306AM Ref By Final HEATITIS A & B VIRUS EVALUATION HEATITIS A ANTIBODY (ANTI HAV),
More informationGLP-2 ELISA. For the quantitative determination of GLP-2 in human serum and plasma samples.
GLP-2 ELISA For the quantitative determination of GLP-2 in human serum and plasma samples. For Research Use Only. Not For Use In Diagnostic Procedures. Catalog Number: 48-GP2HU-E01.1 Size: 96 wells Version:
More informationCitation Acta medica Nagasakiensia. 1986, 30
NAOSITE: Nagasaki University's Ac Title Epidemiology of Hepatitis B Virus i Author(s) Miyamoto, Tsutomu Citation Acta medica Nagasakiensia. 1986, 30 Issue Date 1986-03-20 URL http://hdl.handle.net/10069/15690
More informationUltraviolet Light Upon Influenza Virus Infectivity,
APPuED MICROBIOLOGY, Feb. 197, p. 29-294 Copyright @ 197 American Society for Microbiology Vol. 19, No. 2 Printed in U.S.A. Effect of Formalin, 3-Propiolactone, Merthiolate, and Ultraviolet Light Upon
More informationin the malignant cells themselves, might provide more direct evidence for an oncogenic
Br. J. Cancer (198) 41, 399 HEPATITIS-B SURFACE ANTIGEN IN TUMOUR TISSUE AND NON-TUMOROUS LIVER IN BLACK PATIENTS WITH HEPATOCELLULAR CARCINOMA M. C. KEW, M. B. RAY, V. J. DESMET AND J. DESMYTER From the
More informationRadioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection
J. gen. Virol. (I977), 3 6, ~ 371-375 Printed in Great Britain 371 Radioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection By B. FORGHANI, TONI KLASSEN AND J. R. BARINGER
More informationaV (modules 1 and 9 are required)
This form should be used for all taxonomic proposals. Please complete all those modules that are applicable (and then delete the unwanted sections). For guidance, see the notes written in blue and the
More informationAnti-LSP antibodies in acute liver disease
Anti-LSP antibodies in acute liver disease R MELICONI, A PERPERAS, D JENSEN, A ALBERTI, I G McFARLANE, A L W F EDDLESTON, and ROGER WILLIAMS From the Liver Unit, King's College Hospital and Medical School,
More informationHepatitis A virus IgM ELISA Kit
Hepatitis A virus IgM ELISA Kit Catalog Number KA0285 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationCross-Reactivity to Field Isolates of Canine Influenza Virus by a Killed Canine Influenza Virus (H3N8, Iowa05) Vaccine
Cross-Reactivity to Field Isolates of Canine Influenza Virus by a Killed Canine Influenza Virus (H3N8, Iowa05) Vaccine Nancee Oien, B.S., M.S. a Sally Mattern, B.S a Jaime Brozowski, B.S., M.S. b Janet
More informationChing-Wen Wang, Li-Chieh Wang, Mei-Hwei Chang,* Yen-Hsuan Ni, Huey-Ling Chen, Hong-Yuan Hsu, and Ding-Shin Chen
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Dec. 2005, p. 1442 1447 Vol. 12, No. 12 1071-412X/05/$08.00 0 doi:10.1128/cdli.12.12.1442 1447.2005 Copyright 2005, American Society for Microbiology. All
More informationSUB TYPING OF HEPATITIS B SURFACE ANTIGEN AND ANTIBODY BY RADIOIMMUNOASSAY
GASTROENTEROLOGY 72:290-296, 1977 Copyright 1977 by The Williams & Wilkins Co. Vol. 72, No.2 Printed in U.SA. SUB TYPING OF HEPATITIS B SURFACE ANTIGEN AND ANTIBODY BY RADIOIMMUNOASSAY JAY H. HOOFNAGLE,
More informationAccuVert HBV Seroconversion Panel PHM941(M) ( )
PACKAGE INSERT PHM941(M) (0605-0061) INTENDED USE PHM941(M) (0605-0061) is a group of serial bleeds from an individual plasma donor during HBV seroconversion. This panel is intended for use by diagnostics
More informationAnti-HBs. Intended Use
Anti-HBs Principle of the Test The ImmunoComb II Anti-HBs test is a solid-phase enzyme immunoassay (EIA), based on a dual recognition principle. The solid phase is a card with 12 projections ("teeth").
More informationThe ABCs of Viral Hepatitis Diagnosis. Ila Singh, M.D., Ph.D. P & S Viral Hepatitis. Hepatitis A, B, C, D, E and G viruses
The ABCs of Viral Hepatitis Diagnosis Ila Singh, M.D., Ph.D. P & S 14-453 is132@columbia.edu Viral Hepatitis Hepatotropic viruses Hepatitis A, B, C, D, E and G viruses Generalized infection plus infection
More informationDelta-Associated Particle
INFECTION AND IMMUNITY, Mar. 1984, p. 1000-1005 0019-9567/84/031000-06$02.00/0 Copyright 1984, American Society for Microbiology Vol. 43, No. 3 Delta Hepatitis Agent: Structural and Antigenic Properties
More informationImproved economics of HBsAg screening with commercial radioimmunoassay reagents
Improved economics of HBsAg screening with commercial radioimmunoassay reagents R HOPKINS, SYLVIA ROSS, T JORDAN, AND AD WATT J Clin Pathol 1980; 33: 19-23 From the Microbiology Division, South-East Scotland
More informationTrichinella Cat #
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationFOR REFERENCE USE ONLY ETI-CORE-IGMK PLUS
ETI-CORE-IGMK PLUS Enzyme Immunoassay for the Detection of IgM Antibody to Hepatitis B Core Antigen (IgM anti-hbc) in Human Serum or Plasma Instruction Manual Catalog No.: P001928 Manufactured By: DiaSorin
More informationHepatitis B virus core antigen Ab ELISA Kit
Hepatitis B virus core antigen Ab ELISA Kit Catalog Number KA0288 96 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the
More informationHIV-1/2 Ab ELISA Kit. Catalog Number KA assays Version: 12. Intended for research use only.
HIV-1/2 Ab ELISA Kit Catalog Number KA0292 96 assays Version: 12 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...
More informationBasics of hepatitis B diagnostics. Dr Emma Page MRCP MD(Res) Locum Consultant Sexual Health & Virology
Basics of hepatitis B diagnostics Dr Emma Page MRCP MD(Res) Locum Consultant Sexual Health & Virology Basics of hepatitis B diagnostics Background Epidemiology Morphology Life-cycle Diagnostic markers
More informationHIV-1 p24 ELISA Kit. purified polyclonal antibody raised against the full length recombinant p24 is used.
HIV-1 p24 ELISA Kit 80-001 1 kit 96 assays This kit can measure the amount of HIV-1 Gag p24 antigen in cell culture medium handily by a sandwich ELISA (Enzyme Linked Immunosorbent Assay) method. p24 antigen
More informationMouse C-peptide EIA. Cat. No. YII-YK013-EX FOR LABORATORY USE ONLY
Mouse C-peptide EIA Cat. No. YII-YK013-EX FOR LABORATORY USE ONLY TOYO 2CHOME, KOTO-KU, TOKYO, 135-0016, JAPAN http://www.cosmobio.co.jp e-mail : export@cosmobio.co.jp Phone : +81-3-5632-9617 FAX : +81-3-5632-9618
More informationhowever, and the present communication is concerned with some of
THE AGGLUTINATION OF HUMAN ERYTHROCYTES MODIFIED BY TREATMENT WITH NEWCASTLE DISEASE AND INFLUENZA VIRUS' ALFRED L. FLORMAN' Pediatric Service and Division of Bacteriology, The Mount Sinai Hospital, New
More informationMouse GLP-2 EIA. Cat. No. KT-374. For the quantitative determination of GLP-2 in mouse serum or plasma. For Research Use Only. 1 Rev.
Mouse GLP-2 EIA For the quantitative determination of GLP-2 in mouse serum or plasma. Cat. No. KT-374 For Research Use Only. 1 Rev. 11357374 PRODUCT INFORMATION Mouse GLP-2 EIA Cat. No. KT-374 INTENDED
More information